Global Drug Supply at Risk Amid Middle East Tensions

Global Drug Supply at Risk Amid Middle East Tensions
———————————-
Ongoing military conflicts in the Middle East are disrupting transport routes and energy supplies, threatening the global drug supply and making access to essential medicines more difficult and expensive for patients worldwide.

Experts warn that these disruptions could worsen in the coming months, affecting pharmaceutical companies, healthcare providers, and patients. Rising shipping costs, fuel prices, insurance premiums, and temporary factory closures have placed unprecedented pressure on the global drug market.

Former WHO senior scientist Soumya Swaminathan cautioned that continued supply chain interruptions may lead to drug shortages and higher treatment costs, while analysts in India estimate hundreds of millions of dollars in losses for the pharmaceutical industry.

Reports from Iran indicate price surges of 101–3,380% for some medications, leaving many families unable to afford essential treatments. In Sudan, patients in conflict zones are forced to delay or skip doses due to lack of access.

Health advocates urge immediate international action to reduce tensions and ensure uninterrupted delivery of medicines and medical supplies to vulnerable populations.